ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2,401 | 87.06097 | 1 | female | 0 | 8 | 1,109 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 9,141 | 5,488.5938 | null | 10.5 | white | 18.796875 | 22 | 0.753906 | 0.611938 | 1 | 0 | 0 | no | 0.8 | 0.6 | dnr after sadm | 1 | 83 | 6.799805 | 60 | 20 | 36.09375 | 185.6875 | null | 0.199982 | 1.299805 | 142 | 7.269531 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
2,402 | 60.745 | 0 | female | 0 | 9 | 1,313 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | under $11k | 9 | 14,478 | 4,920.8438 | null | 26 | black | 30.199219 | 29 | 0.622925 | 0.518921 | 1 | 0 | 0 | yes | 0.75 | 0.5 | no dnr | 9 | 42 | 11.199219 | 112 | 16 | 38.09375 | 524 | 2.799805 | 1.199951 | 1 | 144 | 7.399414 | null | null | null | null | 6 | adl>=4 (>=5 if sur) | 6 |
2,403 | 52.86499 | 1 | female | 0 | 11 | 23 | Lung Cancer | Cancer | 1 | 11 | >$50k | 0 | 20,940 | 11,508.2656 | null | 15.5 | white | 22.597656 | 11 | 0.615967 | 0.300964 | 1 | 0 | 0 | metastatic | 0.5 | 0.3 | dnr after sadm | 3 | 80 | 15.798828 | 70 | 30 | 37.69531 | null | 2.899902 | 0.199982 | 0.799927 | 141 | null | null | null | null | 3 | 5 | <2 mo. follow-up | 5 |
2,404 | 69.04895 | 1 | male | 1 | 12 | 12 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 12 | null | 0 | 49,859 | 28,440.2969 | null | 34 | white | 31.5 | 52 | 0.587891 | 0.478943 | 6 | 1 | 0 | no | 0.6 | 0.55 | dnr after sadm | 11 | 63 | 8.699219 | 110 | 8 | 36.19531 | 130 | 2.899902 | 0.899902 | 8.099609 | 134 | 7.399414 | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
2,405 | 66.31097 | 1 | female | 0 | 18 | 92 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | null | 0 | 56,614 | 41,906.9375 | null | 22 | white | 23.097656 | 34 | 0.764893 | 0.626953 | 13 | 0 | 0 | no | 0.4 | 0.3 | no dnr | 18 | 62 | 7.5 | 69 | 24 | 36.79688 | 163.25 | 3.799805 | null | 3.099609 | 134 | 7.429688 | null | null | null | 4 | null | no(M2 and SIP pres) | 3.183199 |
2,406 | 71.86896 | 0 | male | 0 | 121 | 1,307 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 16 | >$50k | 0 | 195,312 | 104,546.312 | null | 28.5 | white | 29.296875 | 47 | 0.68689 | 0.594971 | 1 | 0 | 0 | no | null | null | dnr after sadm | 2 | 59 | 4 | 62 | 5 | 39.09375 | 195 | 2.199707 | 0.5 | 0.5 | 131 | 7.469727 | null | null | null | null | 5 | no(M2 and SIP pres) | 5 |
2,407 | 67.92096 | 1 | male | 0 | 9 | 210 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $25-$50k | 0 | 12,316 | 7,214.0312 | null | 14.5 | white | 19 | 20 | 0.825928 | 0.766968 | 1 | 0 | 0 | yes | 0.5 | 0.3 | no dnr | 9 | 77 | 22.199219 | 80 | 25 | 36.09375 | 367.5 | null | 1.199951 | 0.899902 | 141 | 7.479492 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
2,408 | 77.24298 | 1 | male | 0 | 4 | 583 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | $25-$50k | 0 | 4,298 | 2,533.3926 | null | 15 | white | 18.699219 | 17 | 0.775879 | 0.641968 | 1 | 0 | 0 | yes | 1 | 0.9 | no dnr | 4 | 87 | 12.398438 | 80 | 20 | 36.09375 | 395 | null | null | 1.699951 | 139 | 7.329102 | null | null | null | null | null | no(M2 and SIP pres) | 2.838867 |
2,409 | 66.97095 | 0 | female | 0 | 9 | 1,305 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 8 | under $11k | 100 | 11,884 | 5,305.3516 | null | 14.5 | black | 35 | 50 | 0.054993 | 0.017998 | 1 | 1 | 0 | yes | 0.9 | 0.9 | dnr before sadm | -1 | 47 | 9.798828 | 98 | 11 | 36.29688 | 486.625 | 4.5 | 0.5 | 0.5 | 168 | 7.319336 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
2,410 | 31.05299 | 0 | female | 0 | 50 | 1,305 | MOSF w/Malig | ARF/MOSF | 2 | 12 | $11-$25k | 0 | 238,115 | 116,004.25 | null | 43.5 | white | 42 | 77 | 0.274963 | 0.166992 | 1 | 0 | 0 | yes | 0.7 | 0.5 | no dnr | 50 | 51 | 0.899902 | 134 | 12 | 38.29688 | 132 | 1.799805 | 1.799805 | 2 | 145 | 7.339844 | null | null | null | null | 3 | adl>=4 (>=5 if sur) | 3 |
2,411 | 63.452 | 1 | male | 1 | 8 | 8 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $25-$50k | 0 | 30,733 | 10,592.25 | null | 31.5 | white | 29 | 34 | 0.671997 | 0.575928 | 7 | 0 | 0 | no | 0.97 | 0.98 | no dnr | 8 | 76 | 12.099609 | 104 | 32 | 39.29688 | 116.65625 | 2.799805 | null | 0.799927 | 132 | 7.459961 | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
2,412 | 61.29999 | 1 | male | 1 | 21 | 21 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 0 | 148,632 | 93,047.125 | null | 58.333313 | null | 48.296875 | 69 | 0.181976 | 0.093994 | 4 | 0 | 0 | no | 0.25 | 0.2 | dnr after sadm | 19 | 50 | 39.296875 | 110 | 8 | 33.69531 | 61 | null | 3.299805 | 1.299805 | 132 | 7.349609 | null | null | null | null | null | <2 mo. follow-up | 2.48877 |
2,413 | 55.78897 | 1 | male | 0 | 16 | 82 | Lung Cancer | Cancer | 2 | null | null | 0 | 19,538 | 11,818.8594 | null | 19.666656 | null | 22.699219 | 23 | 0.60498 | 0.287964 | 1 | 0 | 0 | metastatic | 0.15 | 0.05 | no dnr | 16 | 113 | 7.299805 | 96 | 32 | 38.69531 | 171.65625 | 3.099609 | 0.399963 | 1.099854 | 139 | 7.5 | null | null | null | null | null | null | 3.235352 |
2,414 | 87.25494 | 1 | female | 0 | 10 | 348 | COPD | COPD/CHF/Cirrhosis | 1 | 12 | under $11k | 9 | 16,061 | 10,449.7344 | 11,553.5859 | 19.5 | white | 20.597656 | 31 | 0.687988 | 0.520996 | 1 | 0 | 0 | no | 0.5 | 0.1 | no dnr | 10 | 67 | 8.599609 | 100 | 16 | 36.89844 | null | null | null | 1.199951 | 138 | null | null | 19 | 750 | null | 2 | no(M2 and SIP pres) | 2 |
2,415 | 46.30298 | 1 | female | 0 | 4 | 333 | Lung Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 14,642 | 7,322.0742 | 2,511.67969 | 11 | white | 14.798828 | 5 | 0.785889 | 0.550903 | 1 | 0 | 0 | metastatic | 0.9 | 0.7 | no dnr | 4 | 73 | 13.5 | 105 | 23 | 38.19531 | 100 | null | null | 3.699707 | 127 | 7.389648 | null | 78 | 3,100 | null | null | no(M2 and SIP pres) | 2.73877 |
2,416 | 83.67096 | 1 | female | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 0 | 12,886 | 2,669.707 | 9,251.5 | 24 | white | 26.398438 | 45 | 0.688965 | 0.596924 | 1 | 0 | 0 | no | 0.75 | 0.7 | dnr after sadm | 4 | 50 | 12.099609 | 105 | 16 | 36.09375 | null | 3.599609 | 1.199951 | 1.299805 | 125 | null | null | 39 | 5,180 | 1 | null | <2 mo. follow-up | 1.166748 |
2,417 | 49.69498 | 0 | male | 0 | 10 | 1,090 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 9 | null | 0 | 15,399 | 9,213.6016 | 9,007.91406 | 18.5 | black | 25.699219 | 51 | 0.832886 | 0.775879 | 1 | 0 | 0 | no | 0.95 | 0.92 | no dnr | 10 | 102 | 14.798828 | 130 | 30 | 39 | 155 | null | null | 0.5 | 130 | 7.5 | 147 | 13 | 1,530 | 0 | 0 | SIP>=30 | 0 |
2,418 | 82.237 | 1 | female | 0 | 14 | 245 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 0 | 41,176 | 18,947.2656 | 25,436.6719 | 22 | white | 22.597656 | 29 | 0.678955 | 0.584961 | 3 | 0 | 0 | yes | 0.9 | 0.7 | no dnr | 14 | 68 | 0.799927 | 120 | 18 | 38.09375 | 152 | 2.099609 | 6.299805 | 2.5 | 127 | 7.289062 | 215 | 77 | 2,010 | 2 | 1 | SIP>=30 | 1 |
2,419 | 74.40399 | 1 | female | 0 | 8 | 805 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 16 | >$50k | 0 | 12,160 | 6,177.9922 | 6,558.64844 | 10.5 | white | 14.298828 | 22 | 0.795898 | 0.671997 | 1 | 0 | 0 | no | 0.92 | 0.7 | no dnr | 8 | 63 | 21 | 124 | 36 | 36 | 319 | 2.699707 | 0.599976 | 1.199951 | 147 | 7.359375 | 226 | 44 | 1,027 | 3 | null | no(M2 and SIP pres) | 2.510742 |
2,420 | 85.224 | 1 | male | 1 | 14 | 14 | ARF/MOSF w/Sepsis | ARF/MOSF | 6 | 20 | >$50k | 0 | 67,876 | 49,520.2188 | 45,099.1875 | 29.666656 | white | 24.199219 | 57 | 0.56897 | 0.457947 | 14 | 1 | 0 | yes | 0.3 | 0.3 | dnr after sadm | 4 | 81 | 9.599609 | 100 | 20 | 38.39844 | null | null | null | 0.799927 | 132 | null | 108 | 12 | 2,650 | null | 7 | <2 mo. follow-up | 7 |
2,421 | 87.60797 | 1 | female | 1 | 25 | 25 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $25-$50k | 26 | 93,347 | 58,623.625 | 58,592.0625 | 15.25 | white | 23.796875 | 45 | 0.517944 | 0.401978 | 17 | 0 | 0 | no | 0.8 | 0.6 | dnr after sadm | 24 | 112 | 6.299805 | 115 | 10 | 35 | 230 | 2.399902 | 16.097656 | 1.799805 | 145 | 7.449219 | 296 | 34 | 1,494 | null | 1 | <2 mo. follow-up | 1 |
2,422 | 68.18896 | 0 | female | 0 | 37 | 1,088 | COPD | COPD/CHF/Cirrhosis | 3 | 14 | under $11k | 0 | 81,038 | 25,616.6562 | 67,540.75 | 25.25 | white | 28 | 20 | 0.733887 | 0.582886 | 1 | 0 | 0 | no | 0.75 | 0.7 | no dnr | 37 | 55 | 6.5 | 45 | 10 | 36.29688 | null | null | null | 0.399963 | 141 | null | null | 16 | 1,775 | null | 3 | no(M2 and SIP pres) | 3 |
2,423 | 58.46698 | 0 | male | 0 | 5 | 1,088 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | 19 | >$50k | 0 | 6,816 | 3,522.6035 | 4,406.54688 | 7 | white | 20.597656 | 40 | 0.790894 | 0.66394 | 1 | 0 | 0 | no | 0.9 | 0.75 | no dnr | 5 | 79 | 11.699219 | 72 | 16 | 38 | null | null | 0.699951 | 0.899902 | 138 | null | null | null | 3,900 | 0 | 1 | SIP>=30 | 1 |
2,424 | 72.62396 | 1 | female | 0 | 27 | 37 | Lung Cancer | Cancer | 3 | 8 | under $11k | 0 | 29,597 | 17,250.1875 | 23,536.5156 | 8.75 | white | 22.5 | 18 | 0.559937 | 0.237 | 1 | 0 | 0 | metastatic | 0.15 | 0.04 | dnr after sadm | 2 | 127 | 7.799805 | 130 | 52 | 38.5 | null | 2 | 0.899902 | 0.5 | 131 | null | 191 | 16 | 4,185 | null | 0 | <2 mo. follow-up | 0 |
2,425 | 85.05096 | 0 | male | 0 | 19 | 1,086 | COPD | COPD/CHF/Cirrhosis | 1 | 19 | null | 0 | 27,225 | 13,628.3281 | 17,693.3438 | 11 | white | 16.5 | 26 | 0.802979 | 0.681885 | 1 | 0 | 0 | no | 0.95 | 0.8 | no dnr | 19 | 58 | 6 | 125 | 28 | 38.09375 | 150 | null | null | 1.399902 | 133 | 7.489258 | null | 28 | 3,400 | 2 | 0 | no(M2 and SIP pres) | 0 |
2,426 | 88.86798 | 1 | female | 0 | 5 | 8 | Coma | Coma | 0 | null | null | 94 | 4,313 | 2,654.1602 | 2,629.7793 | 6 | white | 19.398438 | 18 | 0.140991 | 0.090988 | 1 | 0 | 0 | no | 0.01 | 0.01 | dnr before sadm | -1 | 53 | 42.09375 | 75 | 12 | 38.89844 | 67 | null | 8.099609 | 5.5 | 155 | 7.419922 | 391 | 98 | null | null | null | <2 mo. follow-up | 3.016113 |
2,427 | 73.39899 | 1 | male | 0 | 3 | 135 | Cirrhosis | COPD/CHF/Cirrhosis | 5 | 10 | under $11k | 0 | 5,160 | 2,640.3477 | 2,933.28906 | 15 | hispanic | 22.699219 | 38 | 0.645996 | 0.46698 | 1 | 1 | 0 | no | 0.5 | 0.3 | dnr after sadm | 2 | 68 | 0.799927 | 120 | 24 | 38 | 297.125 | 2.399902 | 0.799927 | 2.099609 | 141 | 7.429688 | 74 | 21 | 4,070 | 3 | null | adl>=4 (>=5 if sur) | 2.510742 |
2,428 | 90.28296 | 1 | male | 1 | 5 | 5 | Coma | Coma | 1 | 8 | under $11k | 100 | 18,727 | 7,006.1328 | 13,303.1641 | 38 | white | 22 | 45 | 0.038994 | 0.018997 | 4 | 0 | 0 | no | 0 | 0 | dnr after sadm | 2 | 67 | 6.399414 | 46 | 22 | 36.89844 | 251 | null | null | 1.899902 | 137 | 7.439453 | 126 | 28 | 1,370 | null | null | <2 mo. follow-up | 3.491699 |
2,429 | 69.125 | 0 | female | 0 | 9 | 1,080 | COPD | COPD/CHF/Cirrhosis | 4 | 9 | under $11k | 0 | 8,771 | 4,925.7344 | 6,804.16797 | 6.5 | black | 19 | 9 | 0.855957 | 0.762939 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 9 | 93 | 6.5 | 80 | 20 | 36.09375 | null | null | null | 1 | 139 | null | 107 | 17 | 6,050 | 0 | 1 | no(M2 and SIP pres) | 1 |
2,430 | 58.987 | 1 | female | 0 | 7 | 11 | Colon Cancer | Cancer | 1 | 16 | $25-$50k | 0 | 6,447 | 3,819.7754 | 3,711.09961 | 5 | white | 21.296875 | 23 | 0.764893 | 0.514893 | 1 | 0 | 0 | metastatic | 0.2 | 0.02 | dnr after sadm | 1 | 50 | 8.099609 | 50 | 28 | 38.09375 | 171.40625 | 4.399414 | 0.799927 | 1.399902 | 139 | 7.449219 | 109 | 27 | 440 | null | 3 | <2 mo. follow-up | 3 |
2,431 | 73.15796 | 1 | female | 0 | 11 | 679 | COPD | COPD/CHF/Cirrhosis | 2 | 16 | under $11k | 0 | 18,381 | 7,921.2852 | 9,295.98438 | 17.5 | white | 28.5 | 54 | 0.680908 | 0.511963 | 1 | 0 | 0 | no | 0.85 | 0.8 | no dnr | 11 | 107 | 11.099609 | 80 | 25 | 36.09375 | 375 | 2.5 | null | 8.099609 | 130 | 7.359375 | 191 | 69 | 110 | 2 | null | SIP>=30 | 1.838867 |
2,432 | 93.04895 | 0 | male | 0 | 8 | 1,078 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 8 | null | 0 | 16,645 | 7,173.9883 | 11,388.4062 | 16.5 | white | 27.699219 | 43 | 0.487 | 0.368958 | 3 | 1 | 0 | yes | 0.9 | 0.75 | no dnr | 8 | 73 | 14.699219 | 72 | 20 | 35.79688 | 422.1875 | 3.299805 | null | 2.299805 | 142 | 7.429688 | 126 | 44 | 2,140 | 1 | 1 | no(M2 and SIP pres) | 1 |
2,433 | 62.31097 | 1 | female | 1 | 19 | 19 | Coma | Coma | 3 | 12 | under $11k | 100 | 47,340 | 29,971.7969 | 34,933.5312 | 30 | black | 27 | 45 | 0.093994 | 0.054993 | 1 | 1 | 0 | yes | 0.9 | 0.9 | dnr after sadm | 13 | 107 | 4.599609 | 80 | 20 | 36.79688 | null | 2.399902 | 1.5 | 0.799927 | 141 | null | 70 | 7 | 650 | null | 7 | <2 mo. follow-up | 7 |
2,434 | 78.87195 | 1 | female | 0 | 30 | 55 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 8 | under $11k | 0 | 63,298 | 26,520.2656 | 39,171.2188 | 23.25 | white | 28.699219 | 81 | 0.66394 | 0.566895 | 1 | 1 | 0 | no | 0.25 | 0.05 | dnr after sadm | 16 | 67 | 9.898438 | 70 | 8 | 35.89844 | 267.5 | 2.099609 | null | 5.299805 | 133 | 7.359375 | 163 | 97 | 39 | null | 6 | <2 mo. follow-up | 6 |
2,435 | 48.77798 | 1 | female | 0 | 5 | 150 | Lung Cancer | Cancer | 2 | 12 | null | 0 | 7,376 | 3,867.5684 | 3,885.50977 | 13 | white | 24.5 | 11 | 0.582886 | 0.261963 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 5 | 63 | 12.398438 | 70 | 34 | 35.59375 | 315 | null | null | 1.899902 | 135 | 7.379883 | 258 | 90 | 775 | 3 | null | SIP>=30 | 2.510742 |
2,436 | 75.15399 | 1 | female | 0 | 11 | 300 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | >$50k | 0 | 51,018 | 25,412.875 | 31,865.5312 | 29 | white | 27.597656 | 35 | 0.635986 | 0.533936 | 8 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 11 | 53 | 11.099609 | 62 | 10 | 38.19531 | 410 | 2.799805 | 0.199982 | 0.699951 | 128 | 7.40918 | 96 | 14 | 2,820 | 0 | 0 | no(M2 and SIP pres) | 0 |
2,437 | 95.33496 | 1 | female | 0 | 11 | 1,053 | COPD | COPD/CHF/Cirrhosis | 1 | null | >$50k | 0 | 18,790 | 8,041.3633 | 12,426.5391 | 25 | white | 20.097656 | 10 | 0.656982 | 0.480957 | 1 | 0 | 0 | no | 0.8 | 0.5 | dnr after sadm | 2 | 60 | 4.299805 | 80 | 15 | 36.69531 | null | 2.299805 | 7.699219 | 1 | 133 | null | 76 | 23 | 1,150 | null | 4 | no(M2 and SIP pres) | 4 |
2,438 | 43.44998 | 1 | male | 0 | 16 | 251 | MOSF w/Malig | ARF/MOSF | 3 | 14 | $25-$50k | 0 | 67,444 | 43,043.2188 | 44,333.3125 | 38.333313 | white | 51.59375 | 83 | 0.007 | 0.001 | 8 | 0 | 0 | metastatic | 0.5 | 0.2 | no dnr | 16 | 103 | null | 96 | 12 | 36.59375 | null | 3.299805 | 0.399963 | 0.599976 | 132 | null | 168 | 8 | null | null | 0 | null | 0 |
2,439 | 77.81494 | 1 | male | 1 | 3 | 3 | CHF | COPD/CHF/Cirrhosis | 4 | null | null | 100 | 5,391 | 3,145.9785 | 3,294.9082 | 24 | white | 33.09375 | 79 | 0.090988 | 0.014999 | 1 | 0 | 1 | no | null | null | dnr after sadm | 3 | 100 | 14.599609 | 100 | 25 | 36.69531 | 323.75 | 3.899902 | null | 1.099854 | 140 | 7.329102 | 181 | 18 | 1,700 | null | null | <2 mo. follow-up | 6.068359 |
2,440 | 64.85394 | 1 | male | 1 | 14 | 14 | MOSF w/Malig | ARF/MOSF | 4 | 16 | >$50k | 0 | 57,305 | 20,685.6875 | 35,790.0938 | 27.666656 | white | 32.09375 | 55 | 0.452942 | 0.332947 | 3 | 0 | 0 | yes | 0.3 | 0.15 | dnr after sadm | 8 | 70 | 12.298828 | 100 | 30 | 39.39844 | null | null | null | 0.799927 | 139 | null | 143 | 11 | null | null | 1 | <2 mo. follow-up | 1 |
2,441 | 73.17999 | 0 | male | 0 | 9 | 1,072 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 0 | 15,118 | 8,541.5078 | 4,252.26953 | 11.5 | white | 23.597656 | 23 | 0.784912 | 0.714966 | 1 | 0 | 0 | no | 1 | 0.9 | no dnr | 9 | 67 | 11.5 | 100 | 20 | 36.09375 | 292 | 2.699707 | 0.799927 | 1.5 | 130 | 7.479492 | 305 | 49 | 935 | 0 | 0 | no(M2 and SIP pres) | 0 |
2,442 | 77.24298 | 0 | male | 0 | 6 | 1,071 | COPD | COPD/CHF/Cirrhosis | 2 | 15 | $25-$50k | 0 | 9,213 | 4,534.9688 | 5,946.60938 | 9 | white | 20.699219 | 29 | 0.789917 | 0.662964 | 1 | 0 | 0 | no | 0.6 | 0.25 | dnr before sadm | 0 | 63 | 2.199707 | 60 | 15 | 40.29688 | 317.5 | 3.099609 | null | 2.5 | 145 | 7.479492 | 215 | 64 | 1,205 | 0 | 0 | no(M2 and SIP pres) | 0 |
2,443 | 91.16797 | 1 | female | 1 | 11 | 11 | COPD | COPD/CHF/Cirrhosis | 2 | 14 | $11-$25k | 9 | 22,895 | 6,213.3398 | 20,997.8281 | 24.5 | white | 28.296875 | 33 | 0.44696 | 0.245972 | 1 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 6 | 67 | 6.599609 | 80 | 20 | 36.09375 | 173.3125 | null | null | 0.799927 | 136 | 7.259766 | 106 | 6 | null | null | 6 | <2 mo. follow-up | 6 |
2,444 | 45.10599 | 0 | male | 0 | 46 | 1,071 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | null | 0 | 132,956 | 95,915 | 87,665.4375 | 41.5 | white | 19.296875 | 30 | 0.871948 | 0.826904 | 2 | 0 | 0 | yes | 0.5 | 0.5 | no dnr | 46 | 77 | 2.199707 | 130 | 20 | 36.09375 | null | null | null | 0.899902 | 135 | null | 99 | 4 | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
2,445 | 73.61798 | 1 | female | 0 | 12 | 67 | Lung Cancer | Cancer | 4 | 14 | $25-$50k | 0 | 21,745 | 12,838.8906 | 13,445.8672 | 16 | white | 34.195313 | 30 | 0.218994 | 0.022999 | 1 | 0 | 0 | metastatic | 0.3 | 0.1 | dnr after sadm | 3 | 57 | 10 | 67 | 5 | 36.29688 | 210 | 2.799805 | 0.199982 | 0.699951 | 149 | 7.459961 | 162 | 14 | 501 | null | 4 | null | 4 |
2,446 | 87.45197 | 0 | female | 0 | 27 | 1,068 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 0 | 40,903 | 25,369.1562 | 27,328.6406 | 15.5 | white | 19.398438 | 43 | 0.771973 | 0.698975 | 3 | 1 | 0 | no | 0.8 | 0.8 | no dnr | 27 | 53 | 5.799805 | 56 | 16 | 36.79688 | 362.9375 | 2.799805 | 0.299988 | 3.199707 | 137 | 7.379883 | 339 | 64 | 1,705 | null | 1 | no(M2 and SIP pres) | 1 |
2,447 | 72.10999 | 1 | male | 1 | 18 | 18 | ARF/MOSF w/Sepsis | ARF/MOSF | 6 | null | null | 0 | 82,805 | 30,254.5 | 60,945.9375 | 46.666657 | white | 31.796875 | 43 | 0.527954 | 0.411987 | 15 | 1 | 1 | no | 0.5 | 0.4 | dnr after sadm | 14 | 50 | 13.5 | 68 | 30 | 36.09375 | 396.625 | null | 0.299988 | 1.5 | 150 | 7.389648 | 306 | 22 | 855 | null | null | <2 mo. follow-up | 5.959961 |
2,448 | 67.01196 | 1 | male | 0 | 5 | 27 | Colon Cancer | Cancer | 1 | 13 | $11-$25k | 0 | 4,505 | 2,691.5371 | 2,555.98828 | 10 | white | 18.699219 | 24 | 0.789917 | 0.556885 | 1 | 0 | 0 | metastatic | 0.9 | 0.3 | no dnr | 5 | 57 | 78.796875 | 67 | 11 | 35.69531 | 509.5 | 1.899902 | 0.399963 | 4.799805 | 138 | 7.329102 | 150 | 111 | 353 | 0 | 0 | <2 mo. follow-up | 0 |
2,449 | 67.258 | 1 | female | 0 | 4 | 99 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $11-$25k | 0 | 4,037 | 2,270.6152 | 2,148.86914 | 15 | white | 21.296875 | 32 | 0.800903 | 0.678955 | 1 | 0 | 0 | yes | null | null | no dnr | 4 | 77 | 6.699219 | 80 | 20 | 39.39844 | null | 2.699707 | 0.5 | 0.599976 | 135 | null | 118 | 3 | null | 2 | 2 | no(M2 and SIP pres) | 2 |
2,450 | 63.59198 | 1 | female | 1 | 12 | 12 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 0 | 55,293 | 29,078.8281 | 36,228.8438 | 34 | white | 30.097656 | 47 | 0.710938 | 0.622925 | 1 | 0 | 0 | no | 0.7 | 0.7 | dnr after sadm | 11 | 63 | 11.199219 | 60 | 8 | 36.19531 | 116 | null | null | 1.399902 | 150 | 7.439453 | 158 | 43 | 3,081 | 0 | null | <2 mo. follow-up | 0.494751 |
2,451 | 38.81198 | 1 | male | 1 | 10 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 17 | $25-$50k | 0 | 46,577 | 28,459.8281 | 29,525.5 | 42 | white | 29.796875 | 54 | 0.79895 | 0.73291 | 2 | 0 | 0 | no | 0 | 0 | dnr after sadm | 9 | 111 | 7.5 | 50 | 8 | 35.79688 | 362.5 | null | null | 0.799927 | 146 | 7.379883 | 83 | 10 | 3,226 | null | 0 | <2 mo. follow-up | 0 |
2,452 | 72.03595 | 1 | female | 0 | 10 | 816 | CHF | COPD/CHF/Cirrhosis | 4 | 14 | under $11k | 0 | 18,033 | 10,641.3906 | 12,564.7188 | 18.5 | white | 21.097656 | 37 | 0.825928 | 0.716919 | 1 | 1 | 0 | no | 0.75 | 0.75 | no dnr | 10 | 40 | 0.5 | 135 | 30 | 36.69531 | 110 | 1.5 | 3.699707 | 1 | 142 | 7.429688 | 156 | 30 | 2,810 | 5 | 1 | SIP>=30 | 1 |
2,453 | 94.04199 | 1 | female | 0 | 13 | 74 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | null | 0 | 12,115 | 7,034.9492 | 7,291.13672 | 6.5 | white | 15.5 | 51 | 0.758911 | 0.61792 | 1 | 0 | 0 | no | 0.2 | 0.05 | dnr after sadm | 1 | 43 | 6.599609 | 71 | 38 | 35.59375 | 309.5 | 3.699707 | 0.899902 | 2.5 | 137 | 7.419922 | 39 | 139 | 364 | 2 | 6 | SIP>=30 | 6 |
2,454 | 58.29398 | 1 | female | 0 | 7 | 143 | Lung Cancer | Cancer | 1 | 16 | >$50k | 0 | 9,432 | 5,565.1484 | 6,786.11719 | 6.5 | white | 16 | 8 | 0.740967 | 0.475952 | 1 | 0 | 0 | metastatic | 0.95 | 0.5 | no dnr | 7 | 52 | 3.399902 | 72 | 14 | 39.89844 | 95.70312 | 1.5 | 0.5 | 1.299805 | 142 | 7.469727 | 288 | 39 | 1,095 | 0 | null | SIP>=30 | 0.494751 |
2,455 | 79.76996 | 1 | male | 0 | 13 | 224 | CHF | COPD/CHF/Cirrhosis | 3 | 11 | $11-$25k | 0 | 13,059 | 7,513.8086 | 8,096.76953 | 12 | white | 28.699219 | 43 | 0.658936 | 0.483948 | 1 | 0 | 0 | no | 0.8 | 0.2 | dnr after sadm | 1 | 63 | 3 | 50 | 25 | 37.5 | 352.375 | 4.399414 | 0.399963 | 1.399902 | 139 | 7.439453 | 86 | 11 | 1,025 | 0 | 1 | no(M2 and SIP pres) | 1 |
2,456 | 93.5 | 0 | female | 0 | 11 | 1,059 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 17,669 | 7,677.5938 | 12,203.5156 | 17.5 | white | 23.097656 | 35 | 0.707886 | 0.619995 | 1 | 0 | 0 | no | null | null | no dnr | 11 | 100 | 8.699219 | 100 | 20 | 36.09375 | 246 | 3.399902 | 0.399963 | 1.899902 | 137 | 7.269531 | 211 | 34 | 1,175 | null | null | null | 3.571289 |
2,457 | 64.98596 | 0 | male | 0 | 11 | 1,058 | COPD | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 15,358 | 8,118.6953 | 8,780.17969 | 13 | white | 16.898438 | 34 | 0.892944 | 0.821899 | 1 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 11 | 63 | 10.898438 | 49 | 36 | 35.79688 | 215 | 2.5 | 0.5 | 1.099854 | 138 | 7.399414 | 122 | 24 | 2,900 | null | null | null | 3.209473 |
2,458 | 79.21997 | 1 | male | 1 | 13 | 13 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | $11-$25k | 0 | 26,546 | 19,413.3125 | 20,848.8906 | 23 | white | 21 | 46 | 0.718994 | 0.562988 | 1 | 0 | 0 | yes | 0.95 | 0.7 | no dnr | 13 | 60 | 12.5 | 130 | 8 | 38.5 | 276 | 2.299805 | 0.699951 | 1 | 144 | 7.439453 | 148 | 11 | 3,310 | null | 0 | <2 mo. follow-up | 0 |
2,459 | 73.16095 | 1 | female | 0 | 16 | 71 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $11-$25k | 0 | 31,648 | 9,778.0625 | 27,422.9844 | 33 | white | 18.699219 | 34 | 0.767944 | 0.69397 | 1 | 0 | 0 | metastatic | 0.5 | 0.2 | dnr after sadm | 1 | 69 | 10.398438 | 97 | 22 | 36.69531 | 148.5625 | 2.799805 | 0.299988 | 6.5 | 136 | 7.319336 | 82 | 37 | null | 2 | 6 | adl>=4 (>=5 if sur) | 6 |
2,460 | 64.53094 | 1 | female | 0 | 5 | 31 | Colon Cancer | Cancer | 1 | 12 | under $11k | 0 | 6,520 | 3,431.6211 | 3,499.89844 | 15 | white | 16.597656 | 13 | 0.823975 | 0.618896 | 1 | 0 | 0 | metastatic | 0.79 | 0.25 | no dnr | 5 | 127 | 15.398438 | 70 | 30 | 37.89844 | 280 | 2.299805 | null | 0.699951 | 153 | 7.379883 | 299 | 31 | 2,035 | null | 0 | <2 mo. follow-up | 0 |
2,461 | 96.02496 | 1 | male | 0 | 6 | 153 | CHF | COPD/CHF/Cirrhosis | 2 | 0 | $11-$25k | 0 | 5,425 | 3,100.5625 | 3,094.23828 | 11 | white | 18.597656 | 16 | 0.768921 | 0.631958 | 1 | 0 | 0 | no | 0.8 | 0.5 | no dnr | 6 | 52 | 11.798828 | 63 | 10 | 38.59375 | 70 | 2.599609 | 0.5 | 1.599854 | 136 | 7.469727 | 270 | 35 | 2,215 | 0 | 1 | no(M2 and SIP pres) | 1 |
2,462 | 79.61395 | 1 | female | 1 | 8 | 8 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 17 | $11-$25k | 0 | 49,723 | 19,671.1875 | 29,578.6094 | 33 | white | 26.796875 | 40 | 0.634888 | 0.532959 | 7 | 0 | 1 | no | 0.5 | 0.5 | dnr after sadm | 5 | 97 | 7.799805 | 80 | 20 | 36.69531 | null | 3.099609 | 1.699951 | 1.099854 | 138 | null | 88 | 23 | 300 | null | 1 | <2 mo. follow-up | 1 |
2,463 | 80.383 | 1 | male | 0 | 21 | 71 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 9 | 65,194 | 34,252.8438 | 40,685.7188 | 18 | white | 31.097656 | 49 | 0.445984 | 0.326965 | 16 | 0 | 0 | no | 0.2 | 0.2 | no dnr | 21 | 67 | 12 | 70 | 20 | 36.09375 | 280.9375 | 2.699707 | null | 1 | 139 | 7.519531 | 103 | 13 | 1,475 | null | null | null | 3.805176 |
2,464 | 72.82098 | 1 | male | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 16 | >$50k | 0 | 9,040 | 2,867.6523 | 7,223.89844 | 42 | white | 37 | 77 | 0.402954 | 0.283997 | 1 | 0 | 0 | yes | 0.09 | 0.09 | dnr after sadm | 3 | 115 | 30.597656 | 130 | 38 | 36.69531 | 142.84375 | 3.199707 | 0.5 | 0.699951 | 145 | 7.479492 | 259 | 25 | 1,485 | null | null | <2 mo. follow-up | 2.372559 |
2,465 | 62.17899 | 1 | male | 0 | 7 | 840 | CHF | COPD/CHF/Cirrhosis | 4 | null | null | 0 | 12,723 | 4,000.0977 | 7,637.37891 | 13.5 | white | 17 | 24 | 0.895996 | 0.825928 | 1 | 1 | 0 | no | 0.85 | 0.8 | no dnr | 7 | 69 | 14.099609 | 82 | 32 | 38.09375 | 71 | 2.299805 | null | 2.299805 | 136 | 7.389648 | 151 | 31 | 1,975 | null | null | null | 2.155273 |
2,466 | 91.59998 | 0 | female | 0 | 5 | 1,051 | COPD | COPD/CHF/Cirrhosis | 4 | null | null | 9 | 6,892 | 3,620.3379 | 3,669.80859 | 19 | white | 23.199219 | 44 | 0.583984 | 0.390991 | 1 | 0 | 1 | no | 0.75 | 0.5 | dnr before sadm | -1 | 110 | 6.799805 | 80 | 24 | 38.09375 | 220 | 3 | 0.799927 | 6 | 140 | 7.329102 | 106 | 75 | 855 | null | null | null | 6.798828 |
2,467 | 63.70398 | 0 | female | 0 | 7 | 1,052 | COPD | COPD/CHF/Cirrhosis | 1 | 13 | null | 0 | 14,808 | 8,494.9297 | 9,352.98438 | 11.5 | white | 24.097656 | 25 | 0.823975 | 0.713989 | 1 | 0 | 0 | no | 0.95 | 0.95 | dnr after sadm | 3 | 70 | 11.798828 | 80 | 25 | 37 | 344 | 4 | 1.099854 | 1.5 | 134 | 7.549805 | 127 | 61 | 700 | 1 | null | no(M2 and SIP pres) | 1.166748 |
2,468 | 49.94098 | 0 | male | 0 | 6 | 1,052 | CHF | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 6,022 | 3,451.0117 | 3,434.55859 | 9 | white | 13.798828 | 37 | 0.93689 | 0.892944 | 1 | 0 | 0 | no | 0.7 | 0.6 | no dnr | 6 | 73 | 6.5 | 70 | 20 | 36.69531 | null | null | 0.5 | 0.5 | 139 | null | 101 | 12 | null | null | null | null | 2.330566 |
2,469 | 80.65698 | 1 | female | 1 | 16 | 16 | Coma | Coma | 1 | 12 | under $11k | 100 | 52,292 | 35,646.375 | 36,685.375 | 28.666656 | white | 31.296875 | 62 | 0.011999 | 0.004 | 1 | 1 | 0 | no | 0.5 | 0.4 | dnr after sadm | 13 | 107 | 6.599609 | 50 | 25 | 36.09375 | 186.1875 | null | null | 4.5 | 138 | 7.5 | 179 | 70 | 1,900 | null | 0 | <2 mo. follow-up | 0 |
2,470 | 73.185 | 1 | male | 0 | 13 | 23 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | >$50k | 0 | 21,289 | 9,521.3359 | 9,611.84375 | 11 | white | 22.097656 | 22 | 0.795898 | 0.671997 | 1 | 0 | 0 | no | 0.8 | 0.5 | dnr after sadm | 2 | 58 | 14.099609 | 107 | 28 | 39.09375 | 330 | null | null | 0.799927 | 134 | 7.40918 | 252 | 16 | 1,500 | 0 | 0 | <2 mo. follow-up | 0 |
2,471 | 92.35297 | 1 | female | 0 | 5 | 1,037 | CHF | COPD/CHF/Cirrhosis | 4 | 18 | $25-$50k | 9 | 4,530 | 2,524.7617 | 2,891.37891 | 5 | white | 21.296875 | 44 | 0.643921 | 0.463989 | 1 | 0 | 0 | yes | 0.75 | 0.4 | no dnr | 5 | 77 | 15.298828 | 80 | 20 | 36.69531 | 200 | null | null | 1.099854 | 137 | 7.40918 | 169 | 26 | 1,250 | 4 | 3 | no(M2 and SIP pres) | 3 |
2,472 | 71.06897 | 0 | female | 0 | 8 | 1,048 | COPD | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 9,867 | 5,391.0859 | 5,893.84766 | 11 | white | 15 | 11 | 0.886963 | 0.81189 | 1 | 0 | 1 | no | 0.99 | 0.98 | no dnr | 8 | 107 | 14.199219 | 110 | 26 | 36.5 | 313 | null | null | 1 | 137 | 7.429688 | 246 | 28 | 607 | null | null | null | 5.033203 |
2,473 | 70.69098 | 1 | female | 1 | 17 | 17 | Colon Cancer | Cancer | 1 | 12 | under $11k | 0 | 15,326 | 9,194.1484 | 901.73975 | 7.333332 | white | 42 | 35 | 0.194977 | 0.016998 | 1 | 0 | 0 | metastatic | 0.3 | 0.1 | dnr after sadm | 3 | 58 | 11.699219 | 74 | 8 | 37.89844 | 180 | 3.399902 | null | 1.199951 | 142 | 7.389648 | 151 | 24 | 2,885 | null | 7 | <2 mo. follow-up | 7 |
2,474 | 81.45898 | 1 | female | 0 | 24 | 541 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | 12 | under $11k | 0 | 38,340 | 16,256.4531 | 24,652.8594 | 22.666656 | white | 33.898438 | 37 | 0.516968 | 0.40094 | 1 | 1 | 0 | no | 0.6 | 0.6 | no dnr | 24 | 78 | 12.199219 | 76 | 16 | 37.79688 | null | 3.199707 | 0.399963 | 1.099854 | 138 | null | 83 | 19 | null | 2 | 2 | no(M2 and SIP pres) | 2 |
2,475 | 56.85999 | 0 | female | 0 | 22 | 1,047 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 31,629 | 14,054.8281 | 22,525.2812 | 15.333328 | white | 29.5 | 40 | 0.787964 | 0.660889 | 1 | 0 | 0 | no | 0.75 | 0.6 | no dnr | 22 | 60 | 5.599609 | 80 | 20 | 36.09375 | null | null | null | 1.199951 | 129 | null | 109 | 18 | null | 4 | 1 | no(M2 and SIP pres) | 1 |
2,476 | 53.43698 | 1 | female | 1 | 4 | 4 | Lung Cancer | Cancer | 1 | 12 | null | 0 | 4,094 | 2,367.0938 | 3,063.93945 | 11 | white | 40.796875 | 59 | 0.117996 | 0.004999 | 1 | 0 | 0 | metastatic | 0 | 0 | dnr before sadm | -1 | 65 | 16.597656 | 126 | 20 | 36.89844 | 140 | 2.199707 | 0.299988 | 0.899902 | 149 | 7.40918 | 265 | 35 | 2,447 | null | null | <2 mo. follow-up | 2.522949 |
2,477 | 34.72098 | 0 | male | 0 | 5 | 1,042 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 19 | $11-$25k | 0 | 8,854 | 3,487.0508 | 6,401.4375 | 24 | white | 12.798828 | 12 | 0.952881 | 0.935913 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 5 | 133 | 26.296875 | 134 | 22 | 36.09375 | 236.71875 | 3.399902 | 1.399902 | 4.5 | 147 | 7.389648 | 111 | 125 | 1,355 | null | null | no(M2 and SIP pres) | 1.622803 |
2,478 | 49.65399 | 0 | female | 0 | 32 | 1,041 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 13 | null | 0 | 45,260 | 21,936.75 | 27,900.5156 | 20.25 | white | 19.699219 | 32 | 0.866943 | 0.819946 | 1 | 1 | 0 | yes | 0.95 | 0.9 | dnr after sadm | 2 | 43 | 5.899414 | 111 | 15 | 38.59375 | 336 | 2.399902 | 1.199951 | 5.399414 | 151 | 7.389648 | 99 | 70 | 285 | null | 6 | adl>=4 (>=5 if sur) | 6 |
2,479 | 46.78198 | 1 | male | 0 | 7 | 993 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | $25-$50k | 0 | 7,958 | 4,409.9375 | 4,171.21875 | 5.5 | hispanic | 16.597656 | 18 | 0.942993 | 0.902954 | 1 | 0 | 0 | no | 0.98 | 0.96 | no dnr | 7 | 109 | 6.899414 | 65 | 20 | 36.59375 | 524 | null | null | 1.699951 | 139 | 7.509766 | 224 | 30 | 2,100 | 2 | 0 | no(M2 and SIP pres) | 0 |
2,480 | 63.836 | 0 | male | 0 | 4 | 1,039 | Lung Cancer | Cancer | 1 | null | null | 0 | 17,745 | 8,744.4062 | 3,793.07812 | 12 | null | 7.699219 | 12 | 0.850952 | 0.670898 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 4 | 77 | 3.799805 | 80 | 25 | 35.59375 | null | 3.299805 | 1.599854 | 2.099609 | 138 | null | 92 | 53 | 825 | null | null | null | 2.276856 |
2,481 | 76.47894 | 1 | male | 1 | 8 | 8 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 16 | >$50k | 0 | 26,124 | 8,544.6719 | 19,490.6406 | 44 | white | 28.097656 | 48 | 0.620972 | 0.516968 | 1 | 0 | 0 | yes | 0.3 | 0.3 | no dnr | 8 | 110 | 16.398438 | 70 | 25 | 36.69531 | 180 | 3.299805 | null | 0.5 | 136 | 7.399414 | 167 | 17 | 1,590 | null | 0 | <2 mo. follow-up | 0 |
2,482 | 66.04498 | 0 | female | 0 | 76 | 1,038 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $25-$50k | 0 | 162,830 | 148,262.375 | 135,075.75 | 38.25 | white | 45.296875 | 68 | 0.291992 | 0.181 | 1 | 0 | 0 | no | 0.9 | 0.85 | no dnr | 76 | 70 | 6.5 | 80 | 25 | 36.69531 | 319 | 4.199219 | 1.199951 | 1.599854 | 134 | 7.529297 | 106 | 24 | 1,500 | null | null | adl>=4 (>=5 if sur) | 1.987793 |
2,483 | 65.487 | 1 | male | 0 | 24 | 231 | CHF | COPD/CHF/Cirrhosis | 4 | 14 | null | 0 | 40,260 | 22,924.5312 | 25,569.4375 | 19.666656 | white | 24.597656 | 42 | 0.803955 | 0.68396 | 1 | 0 | 0 | no | 0.3 | 0.2 | dnr after sadm | 17 | 47 | 16 | 70 | 10 | 40.19531 | 382 | 3.699707 | 2.5 | 2.199707 | 145 | 7.459961 | 219 | 60 | 1,072 | 0 | 1 | SIP>=30 | 1 |
2,484 | 74.98999 | 0 | female | 0 | 11 | 1,034 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | >$50k | 0 | 51,049 | 32,962.1562 | 32,872.0625 | 24.5 | white | 30.199219 | 48 | 0.590942 | 0.482971 | 5 | 0 | 0 | no | 0.5 | 0.45 | no dnr | 11 | 100 | 9.398438 | 100 | 30 | 36.09375 | 385.125 | 3.199707 | null | 0.699951 | 141 | 7.239258 | 155 | 19 | 775 | 0 | 0 | no(M2 and SIP pres) | 0 |
2,485 | 71.00897 | 1 | female | 1 | 20 | 20 | Coma | Coma | 3 | 12 | under $11k | 100 | 24,582 | 16,148.7969 | 18,534.9219 | 20 | white | 21.5 | 21 | 0.21698 | 0.153992 | 1 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 1 | 57 | 27.796875 | 80 | 20 | 36.09375 | 252.375 | null | null | 1.099854 | 132 | 7.459961 | 90 | 30 | 1,100 | null | 6 | <2 mo. follow-up | 6 |
2,486 | 82.26099 | 1 | male | 0 | 38 | 397 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | null | 0 | 79,617 | 28,075.9219 | 62,717.75 | 33.75 | white | 26.097656 | 61 | 0.636963 | 0.535889 | 1 | 0 | 0 | yes | 0.5 | 0.3 | dnr after sadm | 8 | 107 | 4.799805 | 100 | 20 | 36.09375 | 498.3125 | 3.899902 | 0.299988 | 0.899902 | 135 | 7.359375 | 90 | 18 | null | null | 3 | adl>=4 (>=5 if sur) | 3 |
2,487 | 77.06494 | 1 | female | 0 | 4 | 381 | CHF | COPD/CHF/Cirrhosis | 2 | 11 | $11-$25k | 0 | 4,731 | 2,831.1074 | 2,518.73828 | 16 | white | 13.099609 | 13 | 0.894897 | 0.823975 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 4 | 67 | 20.199219 | 90 | 20 | 36.5 | 404.75 | 3.799805 | 4.099609 | 1.799805 | 143 | 7.549805 | 89 | 44 | null | 7 | 3 | no(M2 and SIP pres) | 3 |
2,488 | 79.91498 | 1 | male | 1 | 12 | 12 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 0 | 35,208 | 28,682.25 | 28,319.8594 | 27.5 | white | 33.695313 | 61 | 0.463989 | 0.344971 | 5 | 1 | 0 | no | 0 | 0 | dnr after sadm | 3 | 41 | 15.398438 | 109 | 28 | 37.69531 | 436.625 | 3 | 0.599976 | 1.699951 | 138 | 7.369141 | 82 | 36 | 2,340 | null | null | <2 mo. follow-up | 3.675293 |
2,489 | 80.05499 | 0 | female | 0 | 27 | 1,033 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 16 | null | 0 | 63,531 | 30,828.3438 | 32,720.3906 | 19.25 | white | 12.099609 | 17 | 0.866943 | 0.819946 | 9 | 0 | 0 | no | 0.7 | 0.65 | no dnr | 27 | 51 | 17.5 | 84 | 29 | 36.29688 | 122.4375 | 3.699707 | null | 1.299805 | 136 | 7.359375 | 200 | 21 | 3,070 | null | 0 | no(M2 and SIP pres) | 0 |
2,490 | 72.25494 | 1 | male | 0 | 7 | 9 | Lung Cancer | Cancer | 2 | null | null | 0 | 5,886 | 3,460.0781 | 4,167.5 | 5.5 | black | 19.296875 | 10 | 0.639893 | 0.33197 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 1 | 40 | 15.699219 | 144 | 4 | 37.19531 | 105 | null | null | 0.899902 | 141 | 7.289062 | 209 | 13 | null | null | null | <2 mo. follow-up | 3.14502 |
2,491 | 41.172 | 1 | female | 0 | 10 | 26 | Colon Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 15,770 | 8,478.8047 | 7,881.73828 | 17.5 | white | 25.699219 | 44 | 0.72998 | 0.457947 | 1 | 0 | 0 | metastatic | 0.5 | 0.25 | dnr after sadm | 6 | 63 | 7.599609 | 72 | 16 | 38.29688 | 305 | 3.399902 | 0.899902 | 0.699951 | 141 | 7.419922 | 107 | 15 | 4,640 | null | 2 | <2 mo. follow-up | 2 |
2,492 | 64.04395 | 1 | male | 0 | 3 | 129 | Colon Cancer | Cancer | 2 | 12 | null | 0 | 2,867 | 1,655.6846 | 1,640.67969 | null | white | 17.898438 | 32 | 0.806885 | 0.586914 | 1 | 1 | 0 | metastatic | 0.7 | 0.1 | no dnr | 3 | 109 | 7.099609 | 129 | 22 | 39.39844 | 246.65625 | null | 0.599976 | 1.199951 | 146 | 7.289062 | 418 | 23 | 3,230 | 0 | null | no(M2 and SIP pres) | 0.494751 |
2,493 | 30.29999 | 0 | female | 0 | 12 | 1,031 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 15 | >$50k | 0 | 47,058 | 21,754.5938 | 41,279.4062 | 16 | black | 34.796875 | 74 | 0.715942 | 0.629883 | 1 | 0 | 0 | yes | 0.85 | 0.75 | no dnr | 12 | 107 | 8.298828 | 110 | 20 | 37.79688 | 247.59375 | null | 0.899902 | 1.199951 | 141 | 7.399414 | 106 | 13 | null | 0 | 0 | no(M2 and SIP pres) | 0 |
2,494 | 79.49896 | 1 | female | 0 | 5 | 83 | Colon Cancer | Cancer | 2 | 14 | under $11k | 0 | 6,147 | 3,362.3672 | 2,897.75977 | 9 | white | 30.097656 | 19 | 0.503906 | 0.18399 | 1 | 0 | 0 | metastatic | 0.3 | 0 | dnr after sadm | 1 | 77 | 6.899414 | 80 | 20 | 37 | null | 4 | 0.299988 | 0.899902 | 135 | null | 98 | 8 | 4,300 | null | null | adl>=4 (>=5 if sur) | 2.431152 |
2,495 | 83.00598 | 1 | female | 0 | 28 | 48 | Coma | Coma | 1 | null | null | 37 | 23,863 | 14,685.375 | 18,159.7344 | 6 | white | 15.398438 | 21 | 0.42395 | 0.349976 | 1 | 0 | 0 | metastatic | 0.1 | 0 | dnr after sadm | 1 | 67 | 26.296875 | 72 | 23 | 39.09375 | 123.32812 | 2.199707 | null | 2.899902 | 135 | 7.359375 | 147 | 63 | 2,535 | null | null | <2 mo. follow-up | 3.220215 |
2,496 | 75.21399 | 1 | male | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 6 | 9 | under $11k | 0 | 14,546 | 5,461.0391 | 10,412.1562 | 24 | white | 38.09375 | 59 | 0.289978 | 0.179993 | 4 | 0 | 1 | yes | 0 | 0 | dnr after sadm | 1 | 40 | 15.5 | 110 | 50 | 38.19531 | 144 | null | 5.099609 | 0.699951 | 139 | 7.509766 | 113 | 16 | 778 | null | null | <2 mo. follow-up | 5.163086 |
2,497 | 62.09198 | 1 | male | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 9 | 102,751 | 54,442.6875 | 56,633.5625 | 44 | white | 22.898438 | 43 | 0.746948 | 0.666992 | 16 | 0 | 0 | no | 0.3 | 0.25 | no dnr | 5 | 107 | 7.899414 | 100 | 20 | 35.59375 | 261.875 | 3.899902 | 1.399902 | 3.099609 | 132 | 7.5 | 89 | 45 | 1,650 | null | null | <2 mo. follow-up | 1.899658 |
2,498 | 80.24896 | 1 | male | 1 | 6 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 0 | 28,091 | 16,275.4766 | 18,633.5938 | 35 | white | 21.5 | 43 | 0.764893 | 0.688965 | 3 | 0 | 0 | no | 0.05 | 0.05 | no dnr | 6 | 127 | 14.199219 | 180 | 36 | 38.09375 | 138 | 2.899902 | null | 0.599976 | 134 | 7.5 | 173 | 9 | 2,540 | null | null | <2 mo. follow-up | 2.225098 |
2,499 | 86.38995 | 1 | male | 1 | 9 | 9 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 9 | 17,556 | 7,838.75 | 11,553.1641 | 33 | white | 26.296875 | 41 | 0.639893 | 0.53894 | 1 | 0 | 0 | no | null | null | dnr after sadm | 1 | 123 | 16.898438 | 120 | 24 | 38.5 | 240 | null | null | 0.699951 | 148 | 7.429688 | 121 | 13 | 810 | null | null | <2 mo. follow-up | 3.976074 |
2,500 | 91.25299 | 1 | female | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 8 | under $11k | 0 | 12,313 | 7,960.0508 | 7,772.60938 | 35 | white | 26.699219 | 49 | 0.641968 | 0.540894 | 1 | 1 | 0 | no | 0.5 | 0.25 | dnr after sadm | 4 | 55 | 9.798828 | 120 | 6 | 38 | 218 | 2.199707 | null | 1.899902 | 148 | 7.40918 | 79 | 41 | 632 | null | null | <2 mo. follow-up | 3.506348 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.